Morgan Stanley Titan Pharmaceuticals Inc Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.26 - $0.48 $0 - $1	3 New	3 $0
Q4 2023 Feb 13, 2024	SELL	$0.26 - $0.48 $3 - $5	-12 Reduced 75.0%	4 $0
Q2 2023 Aug 14, 2023	SELL	$0.65 - $0.82 $7 - $9	-12 Reduced 42.86%	16 $0
Q4 2022 Feb 14, 2023	SELL	$0.77 - $22.8 $9 - $273	-12 Reduced 30.0%	28 $0
Q3 2022 Nov 14, 2022	BUY	$0.53 - $22.6 $12 - $542	24 Added 150.0%	40 $0
Q4 2021 Feb 14, 2022	SELL	$1.02 - $1.93 $92,276 - $174,601	-90,467 Reduced 99.98%	16 $0
Q3 2021 Nov 15, 2021	BUY	$1.87 - $2.57 $169,203 - $232,541	90,483 New	90,483 $169,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.